Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

An orca in Avacha Bay off Kamchatka Peninsula on Russia's Pacific coast. Photo: Yuri Smityuk/TASS via Getty Images

Killer whales' cunning along with their wide-ranging diet make them seem resistant to human-caused disturbances, but a new study finds these apex predators are imperiled by a class of industrial chemicals first banned more than 30 years ago.

The big picture: Many populations of orcas may disappear entirely during the next 100 years due to polychlorinated biphenyls, or PCBs, building up in their tissue. That contamination may cause multiple killer whale populations to crash in the coming decades, which would have a ripple effect throughout the food chain, according to a new study published Thursday in the journal Science.

The background: More than 90 countries have signed an agreement, known as the Stockholm Convention, to destroy stocks of PCBs, but they slowly decompose in the environment.

Because orcas are at the top of the food chain, they have far higher concentrations of PCBs in their system than smaller species lower on the food chain. This occurs because of a process known as biomagnification, through which species at higher trophic levels take in doses of substances accumulated from each step in the food chain.

About 1 to 1.5 million metric tons of PCBs were produced worldwide between 1930 to 1993, the study states.

  • Research shows that PCBs can impair killer whales' reproduction, disrupt orcas' endocrine and immune systems, and slow population growth or even cause them to decline.
  • Orcas used to be widespread throughout the global oceans, but due to PCBs and other factors, only a few populations are gaining numbers.

What they did: The international team of researchers examined available data on PCB concentrations about 350 killer whales worldwide, and compared them to levels known to affect reproduction and immune system functionality.

What they found:

  • More than half of the 19 studied populations of killer whales have "achievable growth rates" that are so low so as to cause them to decline, potentially inexorably.
  • Brazilian, Northeast Pacific Bigg's, Canary Islands, Greenlandic, Hawaiian, Japanese, Strait of Gibraltar and UK orca populations are all "at high risk of collapse over the next 100 years," the study states.
  • Orcas farther away from industrialized countries tend to be better off, such as those in the Arctic and Antarctic.
  • The researchers found far higher amounts of PCBs in killer whale populations that rely on marine mammals and tuna as a food source, since those species have higher levels of PCBs in their system.

The uncertainties: Study co-author Paul Jepson, a specialist in wildlife population health at the Zoological Society of London, told Axios:

"It’s true that modeling is a tool to assess the impact of PCBs – but we acknowledge that all models have some degree of uncertainty.  That said, PCBs as chemicals do lend themselves very well to this type of modeling – because they behave in very predictable ways in killer whale populations."

"I would agree with their findings that these high-risk populations very likely are going through a decline associated with elevated PCBs," said Brendan Hickie, a senior lecturer at Trent University's School of the Environment who was not involved in the study.

The bottom line: This study has implications for conservation efforts, since few populations of killer whales have legal protections, and these are not specific to PCBs.

Go deeper

Caitlin Owens, author of Vitals
2 hours ago - Health

Pfizer CEO feels "liberated" after taking COVID vaccine

Pfizer CEO Albert Bourla. Photo: "Axios on HBO"

Pfizer CEO Albert Bourla tells "Axios on HBO" that he recently received his first of two doses of the company's coronavirus vaccine.

Why it matters: Bourla told CNBC in December that company polling found that one of the most effective ways to increase confidence in the vaccine was to have the CEO take it.

Dan Primack, author of Pro Rata
2 hours ago - Economy & Business

Ripple CEO: SEC lawsuit is "bad for crypto" in the U.S.

Ripple CEO Brad Garlinghouse tells "Axios on HBO" that if his company loses a lawsuit brought by U.S. regulators, it would put the country at a competitive disadvantage when it comes to cryptocurrencies.

Between the lines: The SEC in December sued Ripple, and Garlinghouse personally, for allegedly selling over $1.3 billion in unregistered securities. Ripple's response is that its cryptocurrency, called XRP, didn't require registration because it's an asset rather than a security.

Caitlin Owens, author of Vitals
2 hours ago - Health

Pfizer CEO: "It will be terrible" if COVID-19 vaccine prices limit access

Pfizer CEO Albert Bourla told "Axios on HBO" that it "will be terrible for society" if the price of coronavirus vaccines ever prohibits some people from taking them.

Why it matters: Widespread uptake of the vaccine — which might require annual booster shots — will reduce the risk of the virus continuing to spread and mutate, but it's unclear who will pay for future shots or how much they'll cost.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!